Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma

Medical Journal of Australia

Volumn 165, Issue 8, 1996, Pages 424-427

  O'Brien, Peter C ^a   Roos, Daniel E ^b   Liew, Kuen Hoe ^c   Trotter, Grant E ^d   Barton, Michael B ^e   Walker, Quenten J ^f   Poulsen, Michael G ^g   Olver, Ian N ^b  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d WAIKATO HOSPITAL   (New Zealand)

^e WESTMEAD HOSPITAL   (Australia)

^f Queensland Radium Institute   (Australia)

^g MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE; METHOTREXATE;

ADULT; AGED; AMNESIA; ARTICLE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG FATALITY; DRUG TOXICITY; FEMALE; FOLLOW UP; HUMAN; INFORMED CONSENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MALE; MORBIDITY; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PROBABILITY; PROSPECTIVE STUDY; SEPSIS; SHORT TERM MEMORY; SKULL IRRADIATION; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0029908743     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb138578.x     Document Type: Article

References (25)

1. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US Cancer 1988; 62: 2461-2465.
2. Lutz J, Coleman MP. Trends in primary cerebral lymphoma. Br J Cancer 1994; 70: 716-718.
3. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992; 23: 9-17.
4. Brada M, Dearnaley D, Norwich A, et al. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone, Int J Radiat Oncol Biol Phys 1990; 18: 787-792.
5. Pittman KB, Olweny CLM, North JB, et al. Primary central nervous system lymphoma A report of 9 cases and review of the literature. Oncology 1991; 48: 184-187.
6. Ervin T, Canellos GR. Successful treatment of recurrent primary central nervous system lymphoma with highdose methotrexate. Cancer 1980; 45: 1556-1557.
7. DeAngelis LM, Yahalom J, Thaler HT, et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635-643.
8. Neuwelt EA, Goldman DL, Dahlborg SA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580-1590.
9. Boiardi A, Silvani A, Valentini S, et al. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system - preliminary data J Neurol 1993; 241: 96-100.
10. Bessell EM, Punt J, Firth J, et al. Primary nonHodgkin's lymphoma of the central nervous system: Phase II study of chemotherapy (BVAM) prior to radiotherapy. Clin Oncol 1991; 3: 193-198.
11. Zubred CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man. (i) Comparative therapeutic trial of nitrogen mustard and triethylene-thio phosphoremide. J Chronic Dis 1960; 11: 7-33.
12. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
13. MEDLOG [computer program]. Incline Village, Nev.: Information Analysis Corporation, 1993.
14. Kaplan EL, Meier P Non-parametric estimation from incomplete observation. J Am Stal Assoc 1958; 53: 457-481.
15. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1995; 119: 1093-1104.
16. Grant JW, Isaacson PG. Primary central nervous system lymphoma. Brain Pathol 1992; 2: 97-109.
17. Ling SM, Roach MI, Larson DA, et al. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Cancer 1994; 73: 2570-2582.
18. Ott RJ, Brada MA, Flower MA, et al. Measurement of blood brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991; 27: 1356-1361.
19. Gabbai AA, Hochberg FH, Linggood RM, et al. High-dose methotrexate for non-AIDS primary central nervous system lymphoma: Report of 13 cases. J Neurosurg 1989; 70: 190-194.
20. DeAngelis LM. Current management of primary central nervous system lymphoma. Oncology 1995; 9: 63-71.
21. Schultz C, Scott C, Wasserman T, et al. Pre-irradiation chemotherapy (CTX) with cytoxan, adriamycin, vincristine, and decadron (CHOD) for primary central nervous system lymphoma (PCNSL): Initial report of Radiation Therapy Oncology Group (RTOG) protocol 88-06 [abstract]. J Clin Oncol 1994; 13: 174.
22. O'Neill BR, O'Fallon JR, Earle JD, et al. Primary central nervous system non-Hodgkin's lymphoma. Survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 1995; 33: 663-673.
23. Bleyer WA, Fallavollita J, Robison L, et al. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group. Pediatr Hematol Oncol 1990; 7: 329-338.
24. Gilchrist NL, Caldwell J, Watson ID, et al. Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma. Cancer Chemother Pharmacol 1985; 15: 290-294.
25. Glick JH, Kim K, Earle J, et al. An ECOG randomised phase III trial of CHOP vs CHOP plus radiotherapy for intermediate grade early stage non-Hodgkin's lymphoma [abstract]. J Clin Oncol 1995; 14: 391.